Jade Biosciences Inc. (AVTE)
NASDAQ · Healthcare
Jade Biosciences Inc. EBITDA 2019–2024
Jade Biosciences Inc. annual/quarterly ebitda history and growth rate from 2019 to 2024. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Jade Biosciences Inc. ebitda for the quarter ending December 31, 2024 was -6.4 M, a 70.98% decrease year-over-year.
- Jade Biosciences Inc. ebitda for the twelve months ending December 31, 2024 was -74.3 M.
- Jade Biosciences Inc. annual ebitda for 2024 was -74.3 M, a 8.61% decrease from 2023.
- Jade Biosciences Inc. annual ebitda for 2023 was -81.3 M, a 52.93% increase from 2022.
- Jade Biosciences Inc. annual ebitda for 2022 was -53.2 M, a 131.10% increase from 2021.
- Jade Biosciences Inc. annual ebitda for 2021 was -23.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jade Biosciences Inc. EBITDA — FAQ
Jade Biosciences Inc. (AVTE) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTE's ebitda history?
The chart and table above show Jade Biosciences Inc.'s ebitda by year and by quarter, including the growth rate.